At a glance
ClinicalIndex Comparison RecordN/ACompleted· 98 enrolled
Drug / intervention
Thromboelastometry testingother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Thromboelastometry Prediction Utility for Risk of Abortion
In Brief
An observational study evaluating Thromboelastometry testing for Pregnancy Trimester, First and Abortion, Threatened. Completed, enrolled 98 participants across 1 site.
Detailed Summary
This study will use thromboelastometry in ED patients with vaginal bleeding, as well as healthy pregnant controls, to determine if abnormal results are associated with the presence of vaginal bleeding as well as later complications during pregnancy.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPregnancy Trimester, First, Abortion, Threatened
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartJun 2018
First PostedJun 2018
Primary CompletionMay 2019
TodayJul 2026
First PostedJun 7, 2018
Enrollment StartJun 4, 2018
Primary CompletionMay 15, 2019
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 8.1 years ago
Interventions
Thromboelastometry testingother
Thromboelastometry testing - a form of testing in whole blood for coagulation abnormalities